Edgewise Therapeutics, Inc. (EWTX)

32.83 -0.50 (-1.50%) USD  |  NASDAQ  |  Apr 06, 16:00
32.86 +0.03 (+0.09%) After-Hours: 20:00
More

Edgewise Therapeutics SG&A Expense (TTM) : 40.02M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Glaukos Corp. 331.75M
Nuvalent, Inc. 107.34M
Boston Scientific Corp. 6.888B
Edwards Lifesciences Corp. 2.085B
Eli Lilly & Co. 11.09B